540694 — ANG Lifesciences India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹642.21m
- IN₹1.20bn
- IN₹1.46bn
- 37
- 62
- 13
- 27
Annual cashflow statement for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 61 | 70.3 | 535 | 26.3 | -107 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 52.7 | 61.5 | 109 | 113 | 115 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -76.7 | -52.8 | -456 | 30.6 | -187 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 48.3 | 91.4 | 247 | 264 | -94.9 |
| Capital Expenditures | -16.4 | -42.4 | -413 | -104 | -55.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.145 | -34.5 | -30.7 | 11.2 | 255 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16.6 | -77 | -444 | -93.3 | 199 |
| Financing Cash Flow Items | -29.2 | -29.7 | -79.6 | -117 | -106 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -39.5 | -11.9 | 199 | -171 | -104 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.71 | 2.62 | 2.35 | -0.218 | -0.057 |